Uncategorized Archives - Page 8 of 248

WednesdayMay 29, 2024 11:15 am

Golden Triangle Ventures Inc. (GTVH) Subsidiary Shares New Business Model Based on Key Pillars to Ensure Success

Strategic four-pillar business model provides essential piece of Lavish Entertainment’s mission to create an industry-leading entertainment business New model “represents a bold step forward in our journey to develop Lavish Entertainment into a staple in the entertainment industry,” states CEO The company plans to develop, acquire operations in each of plan’s four areas At the core of Golden Triangle Ventures’ (OTC: GTVH) purpose of pursuing ventures in the health, entertainment and technology sectors lies its focus on vertical integration to cut costs and maximize margins. One of the company’s newest ventures — Lavish Entertainment, its entertainment division — embodies this…

TuesdayMay 28, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study; Maintains Study Pace and Rollout for 2024

Lexaria, a global innovator in drug delivery platforms, just concluded its first dosing for its glucagon-peptide-1 (“GLP-1”) human pilot study #2, GLP-1-H24-2 GLP-1, a class of drugs, has demonstrated the ability to address diabetes and weight loss, albeit with poor oral bioavailability, usually as little as 0.8% Lexaria, through its study, looks to demonstrate the effectiveness of its DehydraTECH(TM) technology in improving GLP-1’s bioavailability, opening up a vast worldwide market Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just concluded its first dosing for its glucagon-peptide-1 (“GLP-1”) human pilot study #2, GLP-1-H24-2 (https://cnw.fm/g0mZl). This follows the recent…

FridayMay 24, 2024 4:20 pm

420 with CNW — New Jersey Lawmaker Introduces Bill Seeking to Cap Medical Cannabis Prices

State officials in New Jersey acknowledge the concerns raised by medical-cannabis patients regarding the steep prices of marijuana products. However, the officials stress their limited authority under existing laws, which grant them no jurisdiction over the pricing policies of dispensaries. Democratic legislator Senator Troy Singleton is looking to neighboring Pennsylvania for inspiration. Pennsylvania’s medical-cannabis law includes a provision allowing state authorities to impose price limits if marijuana prices become exorbitant. Singleton aims to replicate this provision in New Jersey, proposing a bill that would empower the state’s cannabis regulator to impose price limitations on medical-marijuana providers if their pricing practices…

WednesdayMay 15, 2024 10:30 am

Software Effective Solutions Corp. (SFWJ) Subsidiary Looks to Ride Expansion Trend, Moving into Central American Cannabis Markets

The global textile industry is increasingly turning to hemp, celebrating the plant’s ability to enhance soil health, support biodiversity, suppress weeds, and increase yields Central American expansion is part of MedCana’s broader strategy to strengthen its presence in the global cannabis and agricultural technology sectors MedCana is a pioneer in the integration of technology and agriculture, focusing on cannabis and emerging technologies Worldwide, more farmers are opting to grow hemp because of its agricultural benefits. Leveraging that trend, Eko2o Environmental Solutions S.A.S., a majority-owned subsidiary of Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), is expanding operations into Costa Rica and…

WednesdayMay 15, 2024 9:45 am

More Than Just Green: Zoned Properties Inc. (ZDPY) Experts in Complexities of Opening a Cannabis Dispensary

With cannabis legalization exploding nationwide, there are now over 19,500 incorporated U.S. cities, town, and villages that will govern local cannabis regulations Zoned Properties is comprised of a team of experts in cannabis zoning codes utilizing proprietary technology to identify premium cannabis dispensary locations Focused on its dispensary landlord model, the company has listed its largest cultivation property in Arizona for sale for $16 million The cannabis industry is flourishing, but opening a dispensary isn't a walk in the park. Aspiring entrepreneurs face a maze of regulations and considerations beyond simply having a quality supply chain. Unprecedented Geographic Growth California…

TuesdayMay 14, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners with the National Research Council of Canada for DehydraTECH-GLP-1 Mode of Action Investigation

Lexaria, a global innovator in drug delivery platforms, just announced its newest relationship with the National Research Council of Canada (“NRC”) Specific molecular characteristics of the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, processed with Lexaria’s patented DehydraTECH(TM) technology, will be evaluated Previous research has shown that using a DehydraTECH-semaglutide capsule composition yields a 43% higher peak level of semaglutide in blood compared to Rybelsus(R). This has potential for increased weight-loss and diabetic control Lexaria’s management is confident that this partnership will complement the company’s animal and human pharmacokinetic and pharmacodynamic studies for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a…

MondayMay 13, 2024 12:45 pm

Illinois Cannabis Convention & Expo to Attract the Biggest Traders in the Cannabis Spectrum

The NECANN Illinois Cannabis Convention 7 Expo is being held May 31 – June 1, 2024, at the Schaumburg Convention Center, Chicago, IL. One of the biggest cannabis B2B conventions in the country, the event will witness prominent growers, traders, enthusiasts, patients, educators, dealers, and top industry leaders. Newcomers as well as seasoned businesses can showcase their products or unique ideas at the exhibitor booths to gain visibility among the top investors, industries, and traders in the cannabis industry. The exhibitor booths significantly attract the crowds as they have fresh and innovative items on display. Operating since 2014, NECANN events…

FridayMay 10, 2024 4:20 pm

420 with CNW — Reports Confirm DEA Is Close to Reclassifying Marijuana

The U.S. Drug Enforcement Administration (DEA) is set to change the classification of cannabis. The proposal, pending review by the White House Office of Management and Budget (OMB), acknowledges marijuana’s medical potential and implies that it is less prone to abuse compared to other certain drugs. However, it does not advocate for the complete legalization of marijuana for recreational purposes. The move, disclosed by anonymous sources familiar with the matter, signals a major policy change for the DEA and a shift in U.S. drug policy. Once approved, the agency will invite public feedback on moving cannabis from Schedule I to…

ThursdayMay 09, 2024 12:00 pm

CannaCon West Albuquerque to Unite the Southwest Cannabis Industry

Traders, cannabis stakeholders, license holders, physicians, patients, regulatory authorities, entrepreneurs, capital investors, public officials, and enthusiasts, are invited to attend the CannaCon West Albuquerque at the Albuquerque Convention Center on May 17-18, 2024. The event focuses on bringing together all participants in the cannabis industry for two days of intense exploration, interaction, learning, and collaboration. As Albuquerque is witnessing an evolving cannabis industry, this event provides a phenomenal platform for cannabis veterans and newcomers to build a solid new industry. The CannaCon West Albuquerque is engaged in boosting the West’s cannabis industry. The Albuquerque network consists of like-minded cannabis businesses…

ThursdayMay 09, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Set to Extend Operational Runway to 2025 Following Warrant Exercise and Issuance

Lexaria has entered an agreement wherein an existing accredited investor has exercised all their warrants to purchase shares The company has received $4.7 million from this undertaking, prior to deducting estimated offering expenses Proceeds fully fund Lexaria’s entire planned 2024 GLP-1 R&D program, leaving additional excess capital for general purposes Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its entry into a warrant exercise agreement with an existing accredited investor to exercise in full certain existing warrants initially issued in October 2023 and February 2024. The warrants will be exercised at $0.97 and $2.185 per…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized